{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:42Z","timestamp":1792195242786,"version":"4.4.0"},"reference-count":319,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004286","name":"Santen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.exer.2023.109415","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T20:26:13Z","timestamp":1676838373000},"page":"109415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-730X","authenticated-orcid":false,"given":"Najam A.","family":"Sharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Odani-Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Pinchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2023.109415_bib1","series-title":"AbbVie and iSTAR medical announce strategic alliance for the treatment of glaucoma","author":"Abbvie","year":"2022"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/153537020122600302","article-title":"Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle","volume":"226","author":"Abdel-Latif","year":"2001","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib3","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1167\/iovs.05-1639","article-title":"Mitochondrial abnormalities in patients with primary open-angle glaucoma","volume":"47","author":"Abu-Amero","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib4","article-title":"The trabecular meshwork: a basic review of form and function","volume":"2","author":"Abu-Hassan","year":"2014","journal-title":"J. Ocul. Biol."},{"key":"10.1016\/j.exer.2023.109415_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100897","article-title":"Normal and glaucomatous outflow regulation","volume":"82","author":"Acott","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/1673-5374.245465","article-title":"Neuroinflammation as a target for glaucoma therapy","volume":"14","author":"Adornetto","year":"2019","journal-title":"Neural. Regen. Res."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/IJG.0000000000001221","article-title":"Phase 2, randomized, dose-finding studies of omidenepag isopropyl, a selective EP2 agonist, in patients with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Aihara","year":"2019","journal-title":"J. Glaucoma"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10384-021-00868-y","article-title":"Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study","volume":"65","author":"Aihara","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajo.2020.06.003","article-title":"Omidenepag isopropyl versus latanoprost in primary open-angle glaucoma and ocular hypertension: the phase 3 AYAME study","volume":"220","author":"Aihara","year":"2020","journal-title":"Am. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/jop.2019.0044","article-title":"Pharmacokinetics, safety, and intraocular pressure-lowering profile of omidenepag isopropyl, a selective, nonprostaglandin, prostanoid EP2 receptor agonist, in healthy Japanese and caucasian volunteers (phase I study)","volume":"35","author":"Aihara","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10384-020-00748-x","article-title":"Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-\/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study","volume":"64","author":"Aihara","year":"2020","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib12","series-title":"Alcon completes acquisition of Ivantis, Inc., bringing Hydrus microstent into its global surgical portfolio","author":"Alcon","year":"2022"},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib13","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0161-6420(84)34248-8","article-title":"Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals","volume":"91","author":"Alvarado","year":"1984","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib15","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/bjo.2005.081307","article-title":"A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells","volume":"89","author":"Alvarado","year":"2005","journal-title":"Br. J. Ophthalmol."},{"issue":"48","key":"10.1016\/j.exer.2023.109415_bib16","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.1021\/bi00252a016","article-title":"Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals","volume":"33","author":"An","year":"1994","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/108076803321908347","article-title":"Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter","volume":"19","author":"Ansari","year":"2003","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"13","key":"10.1016\/j.exer.2023.109415_bib18","first-page":"3182","article-title":"Detection of prostaglandin EP(1), EP(2), and FP receptor subtypes in human sclera","volume":"42","author":"Anthony","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib19","series-title":"Two-year Results of the InnFocus MicroShunt\u00ae Glaucoma Drainage System in Patients with Primary Open-Angle Glaucoma","author":"Aptel","year":"2018"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib20","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s12325-020-01277-2","article-title":"Fixed-dose combination of netarsudil and latanoprost in ocular hypertension and open-angle glaucoma: pooled efficacy\/safety analysis of phase 3 MERCURY-1 and -2","volume":"37","author":"Asrani","year":"2020","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"Asrani","year":"2000","journal-title":"J. Glaucoma"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/APO.0000000000000229","article-title":"Glaucoma genetics: recent advances and future directions","volume":"5","author":"Aung","year":"2016","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/156652411800615126","article-title":"Senescent phenotype of trabecular meshwork cells displays biomarkers in primary open-angle glaucoma","volume":"11","author":"Babizhayev","year":"2011","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajo.2007.09.001","article-title":"Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments","volume":"145","author":"Bahler","year":"2008","journal-title":"Am. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib25","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","article-title":"Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study","volume":"128","author":"Baker","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","article-title":"Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study","volume":"30","author":"Batlle","year":"2021","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2023.109415_bib27","series-title":"Bausch + lomb and nicox announce FDA approval of VYZULTA\u2122 (latanoprostene bunod ophthalmic solution), 0.024%","year":"2017"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","article-title":"Safety and effectiveness of the PRESERFLO(R) MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study","volume":"5","author":"Beckers","year":"2022","journal-title":"Ophthalmol. Glaucoma."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial","volume":"114","author":"Bengtsson","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ophtha.2008.01.013","article-title":"Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma","volume":"115","author":"Berdahl","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/10807680260362678","article-title":"Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue","volume":"18","author":"Bergh","year":"2002","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bjophthalmol-2015-307000","article-title":"EP3\/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study","volume":"100","author":"Berlin","year":"2016","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0161-6420(97)30172-9","article-title":"Effect of surgery on visual field progression in normal-tension glaucoma","volume":"104","author":"Bhandari","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109415_bib34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fncel.2019.00426","article-title":"Early-stage ocular hypertension alters retinal ganglion cell synaptic transmission in the visual thalamus","volume":"13","author":"Bhandari","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/vision1020015","article-title":"Comparison of Baerveldt 101-350 glaucoma implant (BGI) versus trabeculectomy with ExPress shunt for the treatment of primary open angle glaucoma","volume":"1","author":"Bhatt","year":"2017","journal-title":"Vision"},{"key":"10.1016\/j.exer.2023.109415_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exer.2016.08.022","article-title":"A single gene connects stiffness in glaucoma and the vascular system","volume":"158","author":"Borras","year":"2017","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.22516","article-title":"Early microglia activation in a mouse model of chronic glaucoma","volume":"519","author":"Bosco","year":"2011","journal-title":"J. Comp. Neurol."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib38","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ophtha.2016.04.026","article-title":"Six-month intraocular pressure reduction with a topical bimatoprost ocular insert: results of a phase II randomized controlled study","volume":"123","author":"Brandt","year":"2016","journal-title":"Ophthalmology"},{"issue":"32","key":"10.1016\/j.exer.2023.109415_bib39","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.2174\/1381612821666150909095553","article-title":"Controversies in glaucoma: current medical treatment and drug development","volume":"21","author":"Bucolo","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2014.08.043","article-title":"Five-year treatment outcomes in the Ahmed Baerveldt comparison study","volume":"122","author":"Budenz","year":"2015","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib41","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.jfo.2020.05.002","article-title":"The trabecular meshwork: structure, function and clinical implications. A review of the literature","volume":"43","author":"Buffault","year":"2020","journal-title":"J. Fr. Ophtalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.preteyeres.2004.06.001","article-title":"The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage","volume":"24","author":"Burgoyne","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","article-title":"Trabeculectomy","volume":"66","author":"Cairns","year":"1968","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib44","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1167\/iovs.12-9483i","article-title":"The cell and molecular biology of glaucoma: axonopathy and the brain","volume":"53","author":"Calkins","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib45","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/s41598-020-80954-2","article-title":"MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension","volume":"11","author":"Canut","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib46","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ophtha.2007.10.031","article-title":"Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study","volume":"115","author":"Caprioli","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109415_bib47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preteyeres.2016.12.004","article-title":"Aqueous outflow - a continuum from trabecular meshwork to episcleral veins","volume":"57","author":"Carreon","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib48","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1167\/iovs.14-14515","article-title":"Nitric oxide (NO): an emerging target for the treatment of glaucoma","volume":"55","author":"Cavet","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib49","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4103\/ijo.IJO_2039_20","article-title":"Systemic side effects of topical prostaglandin analogues: rare but real","volume":"68","author":"Chakrabarty","year":"2020","journal-title":"Indian J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib50","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/s41598-020-60558-6","article-title":"Endothelin-1 mediated decrease in mitochondrial gene expression and bioenergetics contribute to neurodegeneration of retinal ganglion cells","volume":"10","author":"Chaphalkar","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00181772","article-title":"The relationship between intraocular pressure and visual field progression in glaucoma","volume":"230","author":"Chauhan","year":"1992","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib52","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1167\/iovs.12-10396","article-title":"Expansion of Schlemm's canal by travoprost in healthy subjects determined by Fourier-domain optical coherence tomography","volume":"54","author":"Chen","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib53","series-title":"Reimagining the complete therapy options for glaucoma","author":"Chew","year":"2020"},{"issue":"30","key":"10.1016\/j.exer.2023.109415_bib54","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1073\/pnas.1402819111","article-title":"Caspase-8 promotes NLRP1\/NLRP3 inflammasome activation and IL-1beta production in acute glaucoma","volume":"111","author":"Chi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exer.2005.07.013","article-title":"The emerging role of proteases in retinal ganglion cell death","volume":"82","author":"Chintala","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2023.109415_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2011.06.005","article-title":"Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion","volume":"1403","author":"Cho","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41433-019-0632-7","article-title":"Clinical implications of recent advances in primary open-angle glaucoma genetics","volume":"34","author":"Choquet","year":"2020","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib58","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.eye.6701663","article-title":"Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes","volume":"19","author":"Chou","year":"2005","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib59","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exer.2003.09.021","article-title":"The ins and outs of aqueous humour secretion","volume":"78","author":"Civan","year":"2004","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/eye.2015.244","article-title":"A view on glaucoma--are we seeing it clearly?","volume":"30","author":"Crabb","year":"2016","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/108076801750125658","article-title":"Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells","volume":"17","author":"Crider","year":"2001","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib62","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1167\/iovs.03-0990","article-title":"Effect of latanoprost on outflow facility in the mouse","volume":"45","author":"Crowston","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib63","article-title":"Correlation of lamina cribrosa and standard automated perimetry findings in glaucoma and non- glaucoma patients","volume":"2","author":"Daguman","year":"2019","journal-title":"J. Ophthalmic. Stud."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-5224.2011.00906.x","article-title":"Astrocytic responses in the lateral geniculate nucleus of monkeys with experimental glaucoma","volume":"15","author":"Dai","year":"2012","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/jop.1999.15.323","article-title":"Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology","volume":"15","author":"Davis","year":"1999","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2023.109415_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exer.2016.06.006","article-title":"Who's lost first? Susceptibility of retinal ganglion cell types in experimental glaucoma","volume":"158","author":"Della Santina","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2023.109415_bib67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnins.2014.00290","article-title":"Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA\/2J mouse model of glaucoma","volume":"8","author":"Dengler-Crish","year":"2014","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bjophthalmol-2020-316888","article-title":"Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial","volume":"106","author":"Denis","year":"2022","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib69","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1167\/iovs.08-3127","article-title":"Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel","volume":"50","author":"Dismuke","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ogla.2019.10.003","article-title":"Comparative outcomes of the Molteno3 and Baerveldt glaucoma implants","volume":"3","author":"Dixon","year":"2020","journal-title":"Ophthalmol. Glaucoma."},{"key":"10.1016\/j.exer.2023.109415_bib71","first-page":"2057","article-title":"A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma","volume":"9","author":"Donnenfeld","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib72","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2147\/OPTH.S221299","article-title":"Twelve-month outcomes of excisional goniotomy using the Kahook Dual Blade((R)) in eyes with angle-closure glaucoma","volume":"13","author":"Dorairaj","year":"2019","journal-title":"Clin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib73","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1167\/iovs.17-23223","article-title":"FOXC1 regulates expression of prostaglandin receptors leading to an attenuated response to latanoprost","volume":"59","author":"Doucette","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib74","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/exer.2000.0975","article-title":"Latanoprost exerts neuroprotective activity in vitro and in vivo","volume":"72","author":"Drago","year":"2001","journal-title":"Exp. Eye Res."},{"issue":"18","key":"10.1016\/j.exer.2023.109415_bib75","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s40265-018-1016-1","article-title":"Omidenepag isopropyl ophthalmic solution 0.002%: first global approval","volume":"78","author":"Duggan","year":"2018","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.eye.6700148","article-title":"The national survey of trabeculectomy. III. Early and late complications","volume":"16","author":"Edmunds","year":"2002","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/biology8020031","article-title":"Mitochondrial dysfunction in the aging retina","volume":"8","author":"Eells","year":"2019","journal-title":"Biology"},{"key":"10.1016\/j.exer.2023.109415_bib78","series-title":"Prostaglandin Conjugates and Derivatives for Treating Glaucoma and Ocular Hypertension","author":"Ellis","year":"2017"},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib79","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1167\/iovs.09-5072","article-title":"Endogenous regulation of human Schlemm's canal cell volume by nitric oxide signaling","volume":"51","author":"Ellis","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib80","first-page":"1","article-title":"European glaucoma society terminology and guidelines for glaucoma","volume":"105","year":"2021","journal-title":"Br. J. Ophthalmol."},{"issue":"13","key":"10.1016\/j.exer.2023.109415_bib81","first-page":"4163","article-title":"Recombinant TIGR\/MYOC increases outflow resistance in the human anterior segment","volume":"41","author":"Fautsch","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ceo.12805","article-title":"Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results","volume":"45","author":"Fea","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/IJG.0000000000000529","article-title":"Evaluation of a trabecular micro-bypass stent in pseudophakic patients with open-angle glaucoma","volume":"25","author":"Ferguson","year":"2016","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2023.109415_bib84","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fendo.2019.00162","article-title":"Asymmetric recruitment of beta-arrestin1\/2 by the angiotensin II type I and prostaglandin F2alpha receptor dimer","volume":"10","author":"Fillion","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2023.109415_bib85","series-title":"Premarket notification: EX-PRESS miniature glaucoma implant","author":"Food and Drug Administration","year":"2002"},{"key":"10.1016\/j.exer.2023.109415_bib86","series-title":"Premarket approval (PMA): glaukos iStent trabecular bypass stent model GTS100R\/L","author":"Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.exer.2023.109415_bib87","series-title":"Premarket studies of implantable minimally invasive glaucoma. Surgical (MIGS) devices - guidance for industry and Food and drug administration staff","author":"Food and Drug Administration","year":"2015"},{"key":"10.1016\/j.exer.2023.109415_bib88","series-title":"Premarket notification: XEN glaucoma treatment system","author":"Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.exer.2023.109415_bib89","series-title":"Premarket approval (PMA): CyPass micro-stent","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.exer.2023.109415_bib90","series-title":"Premarket approval (PMA): Hydrus microstent","author":"Food and Drug Administration","year":"2018"},{"issue":"2\u20133","key":"10.1016\/j.exer.2023.109415_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jop.2013.0205","article-title":"The prostaglandin f2alpha analog fluprostenol attenuates the fibrotic effects of connective tissue growth factor on human trabecular meshwork cells","volume":"30","author":"Fuchshofer","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/jop.2020.0071","article-title":"Additive intraocular pressure-lowering effects of a novel selective EP2 receptor agonist, omidenepag isopropyl, combined with existing antiglaucoma agents in conscious ocular normotensive monkeys","volume":"37","author":"Fuwa","year":"2021","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib93","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/jop.2017.0146","article-title":"Effects of a novel selective EP2 receptor agonist, omidenepag isopropyl, on aqueous humor dynamics in laser-induced ocular hypertensive monkeys","volume":"34","author":"Fuwa","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib94","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ajo.2015.02.018","article-title":"Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study","volume":"159","author":"Garcia-Feijoo","year":"2015","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib95","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/eye.2017.273","article-title":"Selective laser trabeculoplasty: past, present, and future","volume":"32","author":"Garg","year":"2018","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib96","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/bjo.87.6.720","article-title":"Intraocular pressure and visual field loss in primary angle closure and primary open angle glaucomas","volume":"87","author":"Gazzard","year":"2003","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib97","doi-asserted-by":"crossref","first-page":"P30","DOI":"10.1016\/j.ophtha.2020.10.021","article-title":"Primary angle-closure disease preferred practice pattern","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ophtha.2019.10.002","article-title":"Treatment outcomes in the primary tube versus trabeculectomy study after 3 Years of follow-up","volume":"127","author":"Gedde","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib99","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","article-title":"Preferred practice pattern glaucoma primary open-angle glaucoma preferred practice pattern","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109415_bib100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000458490","article-title":"Laser-assisted techniques for penetrating and nonpenetrating glaucoma surgery","volume":"59","author":"Geffen","year":"2017","journal-title":"Dev. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib101","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1139\/y02-163","article-title":"Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors","volume":"81","author":"Gobeil","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib102","first-page":"1188","article-title":"Characterization of ciliary muscle relaxation induced by various agents in cats","volume":"36","author":"Goh","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib103","first-page":"236","article-title":"Pharmacological characterization of prostaglandin-related ocular hypotensive agents","volume":"38","author":"Goh","year":"1994","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archopht.1963.00960040789022","article-title":"Experimental aqueous perfusion in enucleated human eyes","volume":"69","author":"Grant","year":"1963","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib105","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0022-3565(24)35032-3","article-title":"AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor","volume":"290","author":"Griffin","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/IJG.0000000000000956","article-title":"Gonioscopy-assisted transluminal trabeculotomy: an ab interno circumferential trabeculotomy: 24 Months follow-up","volume":"27","author":"Grover","year":"2018","journal-title":"J. Glaucoma"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1167\/iovs.04-0832","article-title":"Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix","volume":"46","author":"Guo","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib108","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.exer.2006.09.013","article-title":"Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain","volume":"84","author":"Gupta","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib109","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archopht.124.6.853","article-title":"Visual field defects and retinal ganglion cell losses in patients with glaucoma","volume":"124","author":"Harwerth","year":"2006","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib110","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1007\/s12035-019-1559-5","article-title":"Rapamycin removes damaged mitochondria and protects human trabecular meshwork (TM-1) cells from chronic oxidative stress","volume":"56","author":"He","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.exer.2023.109415_bib111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2017.0041","article-title":"Targets of neuroprotection in glaucoma","volume":"34","author":"He","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2023.109415_bib112","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0039-6257(02)00293-X","article-title":"Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist","volume":"47","author":"Hellberg","year":"2002","journal-title":"Surv. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/108076801753266802","article-title":"Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist","volume":"17","author":"Hellberg","year":"2001","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib114","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0002-9394(89)90491-1","article-title":"Age-related changes in the extracellular matrix of the human optic nerve head","volume":"107","author":"Hernandez","year":"1989","journal-title":"Am. J. Ophthalmol."},{"issue":"13","key":"10.1016\/j.exer.2023.109415_bib115","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1096\/fj.04-3626fje","article-title":"Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism","volume":"19","author":"Hinz","year":"2005","journal-title":"Faseb. J."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000267739","article-title":"Evidence of constriction of optic nerve axons at the lamina cribrosa in the normotensive eye in humans and other mammals","volume":"27","author":"Hollander","year":"1995","journal-title":"Ophthalmic Res."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib117","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1517\/14656566.2014.936850","article-title":"Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice","volume":"15","author":"Hollo","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib118","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.200706181","article-title":"Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma","volume":"179","author":"Howell","year":"2007","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib119","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40265-018-0914-6","article-title":"Latanoprostene bunod ophthalmic solution 0.024%: a review in open-angle glaucoma and ocular hypertension","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib120","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/bjophthalmol-2019-315280","article-title":"Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma","volume":"104","author":"Hu","year":"2020","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib121","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/IJG.0b013e31817d2372","article-title":"Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004","volume":"18","author":"Huang","year":"2009","journal-title":"J. Glaucoma"},{"issue":"1\u20132","key":"10.1016\/j.exer.2023.109415_bib122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jop.2017.0039","article-title":"Delta opioids: neuroprotective roles in preclinical studies","volume":"34","author":"Husain","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib123","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1089\/jop.2008.0014","article-title":"Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells","volume":"24","author":"Husain","year":"2008","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib124","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1167\/iovs.04-0993","article-title":"Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process","volume":"46","author":"Husain","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib125","first-page":"1127","article-title":"Alterations in arachidonic acid release and phospholipase C-beta(1) expression in glaucomatous human ciliary muscle cells","volume":"43","author":"Husain","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib126","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuint.2009.01.018","article-title":"Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF","volume":"54","author":"Hutchinson","year":"2009","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-021-00745-3","article-title":"Crosstalk between transforming growth factor beta-2 and Autotaxin in trabecular meshwork and different subtypes of glaucoma","volume":"28","author":"Igarashi","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/bph.14328","article-title":"Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma","volume":"176","author":"Impagnatiello","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2023.109415_bib129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajo.2021.12.011","article-title":"Periocular adverse reactions to omidenepag isopropyl","volume":"237","author":"Inoue","year":"2022","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jop.2021.0122","article-title":"One-year efficacy and safety of omidenepag isopropyl in patients with normal-tension glaucoma","volume":"38","author":"Inoue","year":"2022","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11910-018-0831-9","article-title":"Intracranial and intraocular pressure at the lamina cribrosa: gradient effects","volume":"18","author":"Johannesson","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.exer.2023.109415_bib132","series-title":"BAERVELDT\u00ae glaucoma implants","author":"Johnson","year":"2022"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib133","first-page":"1204","article-title":"Human trabecular meshwork cell survival is dependent on perfusion rate","volume":"37","author":"Johnson","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10108","key":"10.1016\/j.exer.2023.109415_bib134","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib135","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1167\/iovs.15-17693","article-title":"Activation of prostaglandin FP and EP2 receptors differently modulates myofibroblast transition in a model of adult primary human trabecular meshwork cells","volume":"57","author":"Kalouche","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib136","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00417-009-1122-6","article-title":"Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo","volume":"247","author":"Kanamori","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14938-0","article-title":"Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork","volume":"7","author":"Kasetti","year":"2017","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.exer.2023.109415_bib138","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1167\/iovs.16-19610","article-title":"Expression of mutant myocilin induces abnormal intracellular accumulation of selected extracellular matrix proteins in the trabecular meshwork","volume":"57","author":"Kasetti","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib139","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib140","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s12325-016-0385-7","article-title":"Long-term safety and efficacy of latanoprostene bunod 0.024% in Japanese subjects with open-angle glaucoma or ocular hypertension: the JUPITER study","volume":"33","author":"Kawase","year":"2016","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib141","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/jpet.102.042556","article-title":"Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors","volume":"304","author":"Kelly","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib142","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3341\/kjo.2021.0169","article-title":"Effect of prostaglandin E2 agonist omidenepag on the expression of matrix metalloproteinase in trabecular meshwork cells","volume":"36","author":"Kim","year":"2022","journal-title":"Kor. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib143","series-title":"Prophylactic And\/or Therapeutic Agent Containing Pyridylaminoacetic Acid Compound","author":"Kirihara","year":"2018"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1167\/iovs.17-22745","article-title":"Pharmacologic characterization of omidenepag isopropyl, a novel selective EP2 receptor agonist, as an ocular hypotensive agent","volume":"59","author":"Kirihara","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2\u20133","key":"10.1016\/j.exer.2023.109415_bib145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2013.0197","article-title":"Emerging trabecular outflow drugs","volume":"30","author":"Kopczynski","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib146","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ceo.12163","article-title":"Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost","volume":"42","author":"Kucukevcilioglu","year":"2014","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib147","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00417-005-0215-0","article-title":"Neuroprotective effect of latanoprost on rat retinal ganglion cells","volume":"244","author":"Kudo","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib148","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ceo.12916","article-title":"Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity","volume":"45","author":"Kwon","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib149","doi-asserted-by":"crossref","first-page":"C1013","DOI":"10.1152\/ajpcell.00599.2020","article-title":"TRPV4-Rho signaling drives cytoskeletal and focal adhesion remodeling in trabecular meshwork cells","volume":"320","author":"Lakk","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2023.109415_bib150","first-page":"2217","article-title":"Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates","volume":"15","author":"Lam","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2023.109415_bib151","first-page":"1937","article-title":"iStent trabecular micro-bypass stent for open-angle glaucoma","volume":"8","author":"Le","year":"2014","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib152","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ophtha.2012.08.047","article-title":"Reversal of lamina cribrosa displacement after intraocular pressure reduction in open-angle glaucoma","volume":"120","author":"Lee","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109415_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.964197","article-title":"Neuroprotection in neurodegenerations of the brain and eye: lessons from the past and directions for the future","author":"Levin","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib154","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","article-title":"Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis","volume":"123","author":"Li","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib155","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0705829","article-title":"Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription","volume":"142","author":"Liang","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib156","first-page":"799","article-title":"Endothelial nitric oxide synthase deficiency influences normal cell cycle progression and apoptosis in trabecular meshwork cells","volume":"9","author":"Liao","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib157","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/946813","article-title":"Role of prostaglandins in neuroinflammatory and neurodegenerative diseases","author":"Lima","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"1\u20132","key":"10.1016\/j.exer.2023.109415_bib158","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib159","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1177\/1060028014548569","article-title":"Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension","volume":"48","author":"Lin","year":"2014","journal-title":"Ann. Pharmacother."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib160","first-page":"1781","article-title":"Reduced TIGR\/myocilin protein in the monkey ciliary muscle after topical prostaglandin F(2alpha) treatment","volume":"42","author":"Lindsey","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib161","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/02713689609017628","article-title":"Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells","volume":"15","author":"Lindsey","year":"1996","journal-title":"Curr. Eye Res."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib162","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0161-6420(94)31152-3","article-title":"Intermediate-term results of a randomized clinical trial of the 350- versus- the 500-mm2 Baerveldt implant","volume":"101","author":"Lloyd","year":"1994","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib163","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1167\/iovs.02-0444","article-title":"Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma","volume":"44","author":"Lo","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051688","article-title":"Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c","volume":"7","author":"Luna","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/mja2.50020","article-title":"Current management of glaucoma","volume":"210","author":"Lusthaus","year":"2019","journal-title":"Med. J. Aust."},{"issue":"52","key":"10.1016\/j.exer.2023.109415_bib166","doi-asserted-by":"crossref","first-page":"20137","DOI":"10.1074\/jbc.RA118.004325","article-title":"Binding of a glaucoma-associated myocilin variant to the alphaB-crystallin chaperone impedes protein clearance in trabecular meshwork cells","volume":"293","author":"Lynch","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib167","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/2008-322X.183914","article-title":"Update on normal tension glaucoma","volume":"11","author":"Mallick","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib168","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/IJG.0000000000000858","article-title":"Prospective evaluation of standalone XEN Gel implant and combined phacoemulsification-XEN Gel implant surgery: 1-year results","volume":"27","author":"Mansouri","year":"2018","journal-title":"J. Glaucoma"},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187711","article-title":"Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR","volume":"12","author":"Matsubara","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.77.2.110","article-title":"The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle","volume":"77","author":"Matsuo","year":"1993","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib171","first-page":"1182","article-title":"Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors","volume":"17","author":"McElnea","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2023.109415_bib172","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajo.2016.05.012","article-title":"Comparison of latanoprostene bunod 0.024% and timolol maleate 0.5% in open-angle glaucoma or ocular hypertension: the LUNAR study","volume":"168","author":"Medeiros","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib173","series-title":"Xen glaucoma treatment system","author":"Mentens","year":"2017"},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib174","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s12325-022-02069-6","article-title":"Efficacy and safety of omidenepag isopropyl 0.002% ophthalmic solution: a retrospective analysis of real-world data in Japan","volume":"39","author":"Miki","year":"2022","journal-title":"Adv. Ther."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bjo.53.9.606","article-title":"New implant for drainage in glaucoma. Clinical trial","volume":"53","author":"Molteno","year":"1969","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib176","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00018-011-0815-2","article-title":"Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle","volume":"69","author":"Morgado","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.exer.2023.109415_bib177","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.04.051","article-title":"The prostanoid EP(2) receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina","volume":"616","author":"Mori","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib178","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jphs.2021.06.005","article-title":"Piezo 1 is involved in intraocular pressure regulation","volume":"147","author":"Morozumi","year":"2021","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib179","first-page":"424","article-title":"Localization of EP(1) and FP receptors in human ocular tissues by in situ hybridization","volume":"42","author":"Mukhopadhyay","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib180","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0006-2952(97)00011-7","article-title":"Detection of EP2, EP4, and FP receptors in human ciliary epithelial and ciliary muscle cells","volume":"53","author":"Mukhopadhyay","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib181","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/IJG.0000000000001442","article-title":"Changes in prostaglandin-associated periorbital syndrome after switch from conventional prostaglandin F2alpha treatment to omidenepag isopropyl in 11 consecutive patients","volume":"29","author":"Nakakura","year":"2020","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2023.109415_bib182","first-page":"61","article-title":"Effects of topical TGF-beta1, TGF-beta2, ATX, and LPA on IOP elevation and regulation of the conventional aqueous humor outflow pathway","volume":"27","author":"Nakamura","year":"2021","journal-title":"Mol. Vis."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib183","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.exer.2006.05.018","article-title":"Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44\/p42 mitogen-activated protein kinase","volume":"83","author":"Nakanishi","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib184","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s12325-021-02035-8","article-title":"Interim results of post-marketing observational study of omidenepag isopropyl for glaucoma and ocular hypertension in Japan","volume":"39","author":"Nakazawa","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.exer.2023.109415_bib185","series-title":"Sept 10, 2021 types of glaucoma","year":"2021"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib186","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ajo.2013.09.014","article-title":"Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study)","volume":"157","author":"Netland","year":"2014","journal-title":"Am. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib187","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.117.8.1050","article-title":"Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma","volume":"117","author":"Neufeld","year":"1999","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib188","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1006\/exer.2002.2042","article-title":"Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase","volume":"75","author":"Neufeld","year":"2002","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2023.109415_bib189","series-title":"Ahmed ClearPath","author":"New World Medical","year":"2022"},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib190","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.survophthal.2020.09.005","article-title":"Microinvasive glaucoma surgery: a review of 3476 eyes","volume":"66","author":"Nichani","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib191","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.neuro.051508.135728","article-title":"Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy","volume":"35","author":"Nickells","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib192","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1167\/iovs.05-1627","article-title":"The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey","volume":"47","author":"Nilsson","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib193","series-title":"Molteno3","author":"Nova","year":"2022"},{"key":"10.1016\/j.exer.2023.109415_bib194","series-title":"Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma","author":"Novartis","year":"2018"},{"key":"10.1016\/j.exer.2023.109415_bib195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.06.006","article-title":"Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: axon transport, injury and soma loss","volume":"141","author":"Nuschke","year":"2015","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib196","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/exer.1998.0508","article-title":"Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections","volume":"67","author":"Ocklind","year":"1998","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib197","first-page":"716","article-title":"Localization of the prostaglandin F2 alpha receptor messenger RNA and protein in the cynomolgus monkey eye","volume":"37","author":"Ocklind","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib198","volume":"vol. 1","author":"Okeke","year":"2017"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib199","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/IJG.0000000000001836","article-title":"A randomized phase 2 trial comparing omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (SPECTRUM-6)","volume":"30","author":"Olander","year":"2021","journal-title":"J. Glaucoma"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib200","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.exer.2010.03.008","article-title":"Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma","volume":"90","author":"Osborne","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib201","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1167\/iovs.05-0494","article-title":"The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice","volume":"46","author":"Ota","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"38","key":"10.1016\/j.exer.2023.109415_bib202","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.1073\/pnas.1410602111","article-title":"Altered mechanobiology of Schlemm's canal endothelial cells in glaucoma","volume":"111","author":"Overby","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib203","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00417-016-3550-4","article-title":"Is there a change in the quality of life comparing the micro-invasive glaucoma surgery (MIGS) and the filtration technique trabeculectomy in glaucoma patients?","volume":"255","author":"Pahlitzsch","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib204","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/1673-5374.286953","article-title":"Roles of the ocular pressure, pressure-sensitive ion channel, and elasticity in pressure-induced retinal diseases","volume":"16","author":"Pang","year":"2021","journal-title":"Neural. Regen. Res."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib205","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archopht.126.5.732","article-title":"Gastrointestinal adverse effects of prostaglandin analogues","volume":"126","author":"Papachristou","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib206","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1167\/iovs.13-12327","article-title":"Torsion of the optic nerve head is a prominent feature of normal-tension glaucoma","volume":"56","author":"Park","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib207","series-title":"Prostaglandin-associated periorbitopathy","author":"Pasquale","year":"2011"},{"issue":"23","key":"10.1016\/j.exer.2023.109415_bib208","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1073\/pnas.2001896117","article-title":"Molecular taxonomy of human ocular outflow tissues defined by single-cell transcriptomics","volume":"117","author":"Patel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib209","first-page":"764","article-title":"Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma","volume":"41","author":"Pease","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib210","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2147\/OPTH.S135316","article-title":"Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents","volume":"11","author":"Pillunat","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib211","article-title":"An ab externo minimally invasive aqueous shunt comprised of a novel biomaterial","volume":"vol. 1","author":"Pinchuk","year":"2019"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.biomaterials.2007.09.041","article-title":"Medical applications of poly(styrene-block-isobutylene-block-styrene) (\"SIBS\")","volume":"29","author":"Pinchuk","year":"2008","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib213","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s004170000203","article-title":"Longitudinal nerve fibre layer thickness change in normal-pressure glaucoma","volume":"238","author":"Poinoosawmy","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib214","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbadis.2014.11.021","article-title":"Autophagic dysregulation in glaucomatous trabecular meshwork cells","volume":"1852","author":"Porter","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.exer.2011.02.015","article-title":"Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma","volume":"93","author":"Prasanna","year":"2011","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib216","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.exer.2010.09.006","article-title":"Endothelin, astrocytes and glaucoma","volume":"93","author":"Prasanna","year":"2011","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib217","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IJG.0000000000001421","article-title":"The influence of translaminar pressure gradient and intracranial pressure in glaucoma: a review","volume":"29","author":"Price","year":"2020","journal-title":"J. Glaucoma"},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib218","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0002-9394(89)90488-1","article-title":"Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma","volume":"107","author":"Quigley","year":"1989","journal-title":"Am. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib219","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238104","article-title":"Astrocyte responses to experimental glaucoma in mouse optic nerve head","volume":"15","author":"Quillen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2023.109415_bib220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","article-title":"The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases","volume":"7","author":"Raker","year":"2016","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib221","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00063030-200721030-00004","article-title":"Rho GTPase\/Rho kinase inhibition as a novel target for the treatment of glaucoma","volume":"21","author":"Rao","year":"2007","journal-title":"BioDrugs"},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib222","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.62.4.4","article-title":"TGF-beta2 promotes oxidative stress in human trabecular meshwork cells by selectively enhancing NADPH oxidase 4 expression","volume":"62","author":"Rao","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib223","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3389\/fimmu.2019.01975","article-title":"Microglia in retinal degeneration","volume":"10","author":"Rashid","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib224","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1111\/j.1460-9568.2007.05528.x","article-title":"Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP","volume":"25","author":"Resta","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exer.2023.109415_bib225","series-title":"Revolutionizing the surgical treatment of glaucoma","author":"Rheon Medical","year":"2022"},{"key":"10.1016\/j.exer.2023.109415_bib226","series-title":"Efficacy and Safety Outcomes with the MicroShunt Glaucoma Drainage System from a 2-year Single-Centre Study","author":"Riss","year":"2018"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib227","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1167\/iovs.09-3380","article-title":"Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats","volume":"51","author":"Robertson","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib228","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1080\/02713683.2021.1899246","article-title":"Stanniocalcin-1 reduced intraocular pressure in two models of ocular hypertension","volume":"46","author":"Roddy","year":"2021","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232591","article-title":"Stanniocalcin-1 (STC-1), a downstream effector molecule in latanoprost signaling, acts independent of the FP receptor for intraocular pressure reduction","volume":"15","author":"Roddy","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib230","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1167\/iovs.16-21004","article-title":"Stanniocalcin-1 is an ocular hypotensive agent and a downstream effector molecule that is necessary for the intraocular pressure-lowering effects of latanoprost","volume":"58","author":"Roddy","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib231","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.bbrc.2005.10.051","article-title":"Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42\/44 mitogen-activated protein kinases","volume":"338","author":"Rosch","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib232","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archopht.123.4.458","article-title":"Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma","volume":"123","author":"Sacca","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib233","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40662-019-0162-1","article-title":"Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review","volume":"6","author":"Sadruddin","year":"2019","journal-title":"Eye Vis. (Lond)"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib234","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","article-title":"Micro-invasive glaucoma surgery: current perspectives and future directions","volume":"23","author":"Saheb","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib235","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ajo.2014.02.027","article-title":"Outcomes of glaucoma reoperations in the tube versus trabeculectomy (TVT) study","volume":"157","author":"Saheb","year":"2014","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib236","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10384-021-00855-3","article-title":"Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis","volume":"65","author":"Sakata","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib237","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjophthalmol-2013-304267","article-title":"Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertension","volume":"98","author":"Sakurai","year":"2014","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib238","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ophtha.2007.03.025","article-title":"Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost","volume":"114","author":"Sakurai","year":"2007","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib239","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/02713683.2011.593725","article-title":"A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension","volume":"36","author":"Schachar","year":"2011","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2310\/JIM.0b013e31819aaa76","article-title":"The anti-inflammatory effects of prostaglandins","volume":"57","author":"Scher","year":"2009","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.exer.2023.109415_bib241","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","article-title":"Intermediate outcomes of a novel standalone ab externo SIBS microshunt with mitomycin C","volume":"215","author":"Schlenker","year":"2020","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib242","first-page":"1475","article-title":"Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues","volume":"43","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib243","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2147\/OPTH.S63760","article-title":"Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs","volume":"8","author":"Schmier","year":"2014","journal-title":"Clin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib244","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00417-003-0638-4","article-title":"Elevation of nitric oxide production in human trabecular meshwork by increased pressure","volume":"241","author":"Schneemann","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib245","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.ophtha.2010.08.049","article-title":"Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure","volume":"117","author":"Sehi","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109415_bib246","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40662-019-0154-1","article-title":"Micro-invasive glaucoma surgery - an interventional glaucoma revolution","volume":"6","author":"Shah","year":"2019","journal-title":"Eye Vis. (Lond)"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib247","first-page":"22","article-title":"Ocular hypertension and glaucoma: a review and current perspectives","volume":"2","author":"Sharif","year":"2017","journal-title":"Int. J.Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib248","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4103\/1673-5374.235017","article-title":"Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision","volume":"13","author":"Sharif","year":"2018","journal-title":"Neural. Regen. Res."},{"issue":"1\u20132","key":"10.1016\/j.exer.2023.109415_bib249","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/jop.2017.0125","article-title":"iDrugs and iDevices discovery research: preclinical assays, techniques, and animal model studies for ocular hypotensives and neuroprotectants","volume":"34","author":"Sharif","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib250","first-page":"dx","article-title":"Research, discovery and development of novel therapeutics for eye diseases allergic conjunctivitis and glaucoma","volume":"2","author":"Sharif","year":"2020","journal-title":"J. Ophthalmic. Stud."},{"key":"10.1016\/j.exer.2023.109415_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.729249","article-title":"Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies","volume":"12","author":"Sharif","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2023.109415_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2022.100037","article-title":"Degeneration of retina-brain components and connections in glaucoma: disease causation and treatment options for eyesight preservation","volume":"3","author":"Sharif","year":"2022","journal-title":"Curr. Res. Neurobiol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib253","article-title":"Rho kinase inhibitors for glaucoma and optic neuropathy treatment: enzyme activity, cell effects, IOP-lowering and neuroprotection perspectives","volume":"7","author":"Sharif","year":"2022","journal-title":"Open Access J. Ophthalmol."},{"key":"10.1016\/j.exer.2023.109415_bib254","series-title":"Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics","first-page":"33","article-title":"Subchapter 1.4 Receptors, ion channels, and signal transduction pathways as targets for drug intervention to mitigate ocular diseases","author":"Sharif","year":"2022"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/1673-5374.343887","article-title":"Neuroaxonal and cellular damage\/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors","volume":"18","author":"Sharif","year":"2023","journal-title":"Neural. Regen. Res."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib256","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/108076803322473006","article-title":"Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation","volume":"19","author":"Sharif","year":"2003","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib257","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1211\/0022357991772989","article-title":"[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor","volume":"51","author":"Sharif","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib258","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/jop.2007.0076","article-title":"Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities","volume":"24","author":"Sharif","year":"2008","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib259","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1167\/iovs.02-0323","article-title":"Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues","volume":"44","author":"Sharif","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib260","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/108076803322660422","article-title":"Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells","volume":"19","author":"Sharif","year":"2003","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib261","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.14335","article-title":"Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility","volume":"176","author":"Sharif","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib262","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jop.2004.20.489","article-title":"Molecular pharmacology of the DP\/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes","volume":"20","author":"Sharif","year":"2004","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2023.109415_bib263","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jop.2005.21.121","article-title":"Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sections","volume":"21","author":"Sharif","year":"2005","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib264","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0022-3565(24)37692-X","article-title":"\"Pharmacology of [3H]prostaglandin E1\/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data","volume":"286","author":"Sharif","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.exer.2023.109415_bib265","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.687246","article-title":"Mitophagy in cerebral ischemia and ischemia\/reperfusion injury","volume":"13","author":"Shen","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib266","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1097\/IJG.0000000000000352","article-title":"Early clinical results of a novel ab interno Gel stent for the surgical treatment of open-angle glaucoma","volume":"25","author":"Sheybani","year":"2016","journal-title":"J. Glaucoma"},{"issue":"8","key":"10.1016\/j.exer.2023.109415_bib267","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.exer.2023.109415_bib268","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.preteyeres.2014.08.002","article-title":"Biomechanics of Schlemm's canal endothelium and intraocular pressure reduction","volume":"44","author":"Stamer","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib269","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1167\/iovs.09-4955","article-title":"Cellular basis for bimatoprost effects on human conventional outflow","volume":"51","author":"Stamer","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib270","first-page":"513","article-title":"Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue","volume":"23","author":"Stjernschantz","year":"1995","journal-title":"Adv. Prostag. Thromb. Leukot. Res."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib271","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.exer.2003.12.007","article-title":"Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug","volume":"78","author":"Takagi","year":"2004","journal-title":"Exp. Eye Res."},{"issue":"1\u20133","key":"10.1016\/j.exer.2023.109415_bib272","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2013.01.038","article-title":"Bimatoprost protects retinal neuronal damage via Akt pathway","volume":"702","author":"Takano","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2023.109415_bib273","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/OPTH.S292007","article-title":"Comparison of safety and efficacy between ab interno and ab externo approaches to XEN Gel stent placement","volume":"15","author":"Tan","year":"2021","journal-title":"Clin. Ophthalmol."},{"issue":"30","key":"10.1016\/j.exer.2023.109415_bib274","article-title":"Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: a meta-analysis","volume":"98","author":"Tang","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib275","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1167\/iovs.10-5289","article-title":"Oxidative stress and the regulation of complement activation in human glaucoma","volume":"51","author":"Tezel","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib276","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109415_bib277","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53 Suppl1","author":"Toris","year":"2008","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib278","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/exer.1994.1158","article-title":"Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2","volume":"59","author":"Tripathi","year":"1994","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib279","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41433-019-0484-1","article-title":"Relationship between intraocular pressure and retinal nerve fibre thickness loss in a monkey model of chronic ocular hypertension","volume":"33","author":"Tu","year":"2019","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib280","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s10792-020-01427-z","article-title":"Xen implantation in patients with primary open-angle glaucoma: comparison of two different techniques","volume":"40","author":"Ucar","year":"2020","journal-title":"Int. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib281","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/s41598-021-83713-z","article-title":"Mechanical stretch induces Ca(2+) influx and extracellular release of PGE2 through Piezo1 activation in trabecular meshwork cells","volume":"11","author":"Uchida","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib282","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ophtha.2014.12.038","article-title":"Association between SNPs of metalloproteinases and prostaglandin F2alpha receptor genes and latanoprost response in open-angle glaucoma","volume":"122","author":"Ussa","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib283","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1167\/iovs.11-9289","article-title":"Transforming growth factor-beta2 induces synthesis and secretion of endothelin-1 in human trabecular meshwork cells","volume":"53","author":"Von Zee","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.exer.2023.109415_bib284","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1167\/iovs.13-12363","article-title":"Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow","volume":"54","author":"Wang","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib285","doi-asserted-by":"crossref","first-page":"816","DOI":"10.18240\/ijo.2020.05.18","article-title":"Progress in the basic and clinical research on the Schlemm's canal","volume":"13","author":"Wang","year":"2020","journal-title":"Int. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib286","first-page":"2560","article-title":"EP3, but not EP2, FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure","volume":"31","author":"Waterbury","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"18","key":"10.1016\/j.exer.2023.109415_bib287","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.exer.2023.109415_bib288","first-page":"2772","article-title":"Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells","volume":"38","author":"Weinreb","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib289","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IJG.0000000000000831","article-title":"Latanoprostene bunod 0.024% in subjects with open-angle glaucoma or ocular hypertension: pooled phase 3 study findings","volume":"27","author":"Weinreb","year":"2018","journal-title":"J. Glaucoma"},{"issue":"6","key":"10.1016\/j.exer.2023.109415_bib290","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bjophthalmol-2014-305908","article-title":"A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study","volume":"99","author":"Weinreb","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib291","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/jop.2019.0146","article-title":"Matrix metalloproteinases and glaucoma treatment","volume":"36","author":"Weinreb","year":"2020","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib292","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2016.01.019","article-title":"Latanoprostene bunod 0.024% versus timolol maleate 0.5% in subjects with open-angle glaucoma or ocular hypertension: the APOLLO study","volume":"123","author":"Weinreb","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib293","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jcp.10032","article-title":"Myocilin is associated with mitochondria in human trabecular meshwork cells","volume":"190","author":"Wentz-Hunter","year":"2002","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib294","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0749.2003.00001.x","article-title":"Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours","volume":"16","author":"Wentzel","year":"2003","journal-title":"Pigm. Cell Res."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib295","first-page":"2515","article-title":"Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide","volume":"35","author":"Wiederholt","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib296","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1350-9462(99)00015-4","article-title":"The regulation of trabecular meshwork and ciliary muscle contractility","volume":"19","author":"Wiederholt","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2023.109415_bib297","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12974-015-0399-0","article-title":"Early pro-inflammatory cytokine elevations in the DBA\/2J mouse model of glaucoma","volume":"12","author":"Wilson","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib298","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/jop.2021.0077","article-title":"Phase 2b, randomized, 3-month, dose-finding study of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: the ANGEL study","volume":"38","author":"Wirta","year":"2022","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.exer.2023.109415_bib299","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/jop.2019.0041","article-title":"Antiglaucoma EP2 agonists: a long road that led somewhere","volume":"35","author":"Woodward","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2023.109415_bib300","series-title":"Blindness and vision impairment","author":"World Health Organization","year":"2022"},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib301","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1167\/iovs.15-18016","article-title":"Glaucoma and the role of cerebrospinal fluid dynamics","volume":"56","author":"Wostyn","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib302","first-page":"129","article-title":"Expression of nitric oxide synthase and guanylate cyclase in the human ciliary body and trabecular meshwork","volume":"125","author":"Wu","year":"2012","journal-title":"Chin. Med. J."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib303","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.ophtha.2014.06.035","article-title":"Optic nerve head deformation in glaucoma: the temporal relationship between optic nerve head surface depression and retinal nerve fiber layer thinning","volume":"121","author":"Xu","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib304","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/iovs.63.2.24","article-title":"The roles played by FP\/EP3 receptors during pressure-lowering in mouse eyes mediated by a dual FP\/EP3 receptor agonist","volume":"63","author":"Yamagishi-Kimura","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.exer.2011.06.022","article-title":"Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction","volume":"93","author":"Yamagishi","year":"2011","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib306","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.14-16181","article-title":"IOP-lowering effect of ONO-9054, A novel dual agonist of prostanoid EP3 and FP receptors, in monkeys","volume":"56","author":"Yamane","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib307","doi-asserted-by":"crossref","first-page":"H886","DOI":"10.1152\/ajpheart.00216.2004","article-title":"Mathematical modeling of the nitric oxide\/cGMP pathway in the vascular smooth muscle cell","volume":"289","author":"Yang","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.exer.2023.109415_bib308","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1167\/iovs.61.10.41","article-title":"Crosslinked extracellular matrix stiffens human trabecular meshwork cells via dysregulating beta-catenin and YAP\/TAZ signaling pathways","volume":"61","author":"Yemanyi","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109415_bib309","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10384-012-0199-3","article-title":"Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases","volume":"57","author":"Yoshino","year":"2013","journal-title":"Jpn. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2023.109415_bib310","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjophthalmol-2019-315616","article-title":"Retinal blood flow reduction in normal-tension glaucoma with single-hemifield damage by Doppler optical coherence tomography","volume":"105","author":"Yoshioka","year":"2021","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib311","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/exer.1996.0119","article-title":"Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species","volume":"63","author":"Yousufzai","year":"1996","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.exer.2023.109415_bib312","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1167\/iovs.07-0984","article-title":"Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues","volume":"49","author":"Yu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib313","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archopht.118.3.378","article-title":"Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma","volume":"118","author":"Yucel","year":"2000","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2023.109415_bib314","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3109\/02713683.2016.1143013","article-title":"PTGFR and SLCO2A1 gene polymorphisms determine intraocular pressure response to latanoprost in han Chinese patients with glaucoma","volume":"41","author":"Zhang","year":"2016","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2023.109415_bib315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jop.1995.11.421","article-title":"Immunocytochemical localization of prostaglandin E2 receptor subtypes in porcine ocular tissues. I. Uveal tissues","volume":"11","author":"Zhao","year":"1995","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.exer.2023.109415_bib316","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1167\/iovs.02-0920","article-title":"Effects of prostaglandin analogues on human ciliary muscle and trabecular meshwork cells","volume":"44","author":"Zhao","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109415_bib317","first-page":"603","article-title":"Versican splice variants in human trabecular meshwork and ciliary muscle","volume":"11","author":"Zhao","year":"2005","journal-title":"Mol. Vis."},{"issue":"4","key":"10.1016\/j.exer.2023.109415_bib318","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10571-011-9653-x","article-title":"Latanoprost promotes neurite outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signaling pathway","volume":"31","author":"Zheng","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3\u20134","key":"10.1016\/j.exer.2023.109415_bib319","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1139\/y05-147","article-title":"Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors","volume":"84","author":"Zhu","year":"2006","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:34:25Z","timestamp":1762148065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483523000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":319,"alternative-id":["S0014483523000362"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2023.109415","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2023.109415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109415"}}